Searched for
SEROPOSITIVITY
Covishield immune responses against Covid variants higher than Covaxin: StudyThe yet-to-be peer-reviewed study, posted on the preprint server MedRxiv on Friday, also found that when compared to pre-vaccination baseli...- Amid Omicron scare, high 'seropositivity' rate should help India, says expertObserving that data on the new SARS-CoV2 variant, Omicron, is still emerging, an expert has said the very high rate of'seropositivity' shou...
- Delhi logs 34 COVID-19 cases, zero death in a dayAccording to the health bulletin, authorities conducted 48,831 tests, including 36,940 RT-PCR ones, the previous day. There are 309 active ...
- Sixth sero survey shows Delhi had seropositivity rate of 97%: Jain"Women had a higher seropositivity rate than men. Those aged below 18 had a seropositivity rate of 88 per cent, while those aged above 18 h...
- Delhi's sixth sero survey: More than 90 per cent have antibodies"We have found Covid antibodies in more than 90 per cent of the samples collected during the sixth round of the survey," an official source...
- Unscientific to extrapolate mortality count from Sero survey, says VK Paul“Sero surveys are carried out for the specific purpose of enunciating how many people have antibodies and previous exposure to Covid-19. Ex...
- Two-thirds of Indians over age of 6 have Covid antibodies: Sero surveyIndian Council of Medical Research director general Balram Bhargava termed the finding a “silver lining” in the country’s fight against the...
- Majority of Mumbai children have antibodies: Sero surveyA paediatric serosurvey conducted by the Mumbai Municipal Corporation (BMC) has shown that 51.18 per cent of children between 1 and 18 year...
- Third wave may not have bigger impact on children: AIIMS-WHO studyConcerns have been raised in India over the probable third wave where children and young age groups were thought to get affected the most. ...
- Government begins tracking data to understand vaccine effectiveness“The system will evaluate the impact of the vaccine. Data harmonisation has started. In the next few weeks we will know the real-world effe...
- Covishield produces more antibodies than Covaxin, finds studyCovishield, from the Oxford-AstraZeneca stable, is manufactured by the Serum Institute of India in Pune. Covaxin is the indigenously manufa...
- Two doses of Covishield, Covaxin produce high levels of immunity, shows studyOxford-AstraZeneca vaccine Covishield is being produced by Serum Institute of India (SII), while Covaxin is manufactured by Bharat Biotech.
- Past COVID-19 infection does not fully protect young people against reinfection: LancetIn the study, conducted between May and November 2020, around 10 per cent or 19 out of 189 participants who were previously infected with S...
- Recurrence of COVID in March could be due to lack of antibodies in seropositive people: CSIR surveyThe CSIR conducted a sero-survey on 10,427 people comprising the staff members of its 40 laboratories, including contractual employees, and...
- Nat’l study: 45% of those tested in December had antibody. It was 18% in JulyThe findings broadly align with sero-surveys in Delhi and Mumbai, said Sandeep Juneja, a senior professor at the Tata Institute of Fundamen...
- COVID-19 recovered people showing faster antibody response to Covishield vaccine: StudyThe study on the immune response to Covishield was carried out by researchers from New Delhi's CSIR-Institute of Genomics and Integrative B...
- COVID-19: Antibodies significantly higher after 7 days of vaccine among those are seropositiveSeropositive people are those who were infected at some point of time. So there are high chances of prevalence of antibodies in them.
- Herd immunity inference from Delhi's sero survey to be taken with pinch of salt, say scientistsOn Tuesday, the Delhi government announced the results of the fifth sero survey, with a sample of 28,000 across 11 districts in Delhi. The ...
- Seropositivity for COVID-19 found to be lesser in smokers, vegetarians: CSIR surveyThe study which was piloted by CSIR-Institute of Genomics and Integrative Biology (IGIB), Delhi said of the 10,427 individuals, 1,058 (10.1...
- India had 6.4 million cases of coronavirus by early May, shows ICMR's sero survey“The low prevalence observed in most districts indicates that India is in the early phase of the epidemic and the majority of the Indian po...
Load More
